Bromide

Bromide

SCHEMBL16633264

Br.Cc1cc(NN)ccn1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 known ✓ P49768 1/20 0.34
PSEN2 known ✓ P49810 1/20 0.34
APH1B known ✓ Q8WW43 1/20 0.34
NCSTN known ✓ Q92542 1/20 0.34
APH1A known ✓ Q96BI3 1/20 0.34
PSENEN known ✓ Q9NZ42 1/20 0.34
UHRF1 Q96T88 1/20 0.48
SMARCA2 P51531 1/20 0.46
SMARCA4 P51532 1/20 0.46
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
SORT1 Q99523 3/20 0.41
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
DYRK1A Q13627 1/20 0.36
KDM4E B2RXH2 1/20 0.35
NOS3 P29474 1/20 0.35
NOS1 P29475 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2476869 0.98
Hydrochloric Acid SCHEMBL27472049 0.96 UHRF1 (0.48) UHRF1SMARCA2SMARCA4HDAC3HDAC1
SCHEMBL883728 0.77
SCHEMBL10138666 0.76
SCHEMBL27629951 0.76
SCHEMBL2885926 0.76
SCHEMBL17621230 0.74 SCN9A (0.51) UHRF1SMARCA2SMARCA4HDAC3HDAC1
SCHEMBL24004058 0.74 KDM4E (0.56) HDAC3HDAC1HDAC2HDAC6MEN1
SCHEMBL1759892 0.73 GOT1 (0.37) SMARCA2SMARCA4KDM4E
SCHEMBL19223206 0.72 UHRF1 (0.46) UHRF1SMARCA2SMARCA4HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296720-B2 Carboxamide-substituted heteroaryl-pyrazoles and the use thereof AICURIS GMBH & CO. KG (DE) 2016-03-29 US disclosed
US-20150105388-A1 CARBOXAMIDE-SUBSTITUTED HETEROARYL-PYRAZOLES AND THE USE THEREOF AICURIS GMBH & CO. KG (DE) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105388-A1 CARBOXAMIDE-SUBSTITUTED HETEROARYL-PYRAZOLES AND THE USE THEREOF PAICS, AADAC, TPMT PSEN1 2153/4885PSEN2 2184/4885APH1B 841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.